This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 44/6/878    most recent 01.HYP.0000145901.81989.46v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Super, M. Articles by Heagerty, A. Search for Related Content PubMed PubMed Citation Articles by Super, M. Articles by Heagerty, A. Related Collections Other hypertension Genetics of cardiovascular disease Hypertension - basic studies

(Hypertension. 2004;44:878.)
© 2004 American Heart Association, Inc.

Scientific Contributions

Blood Pressure and the Cystic Fibrosis Gene

Evidence for Lower Pressure Rises With Age in Female Carriers

Maurice Super; Ayesha Irtiza-Ali; Stephen A. Roberts; Martin Schwarz; Michele Young; Alison Smith; Theresa Roberts; Joanna Hinks; Anthony Heagerty

From the Department of Clinical Genetics (M.S., M.Schwarz, M.Y., A.S., T.R., J.H.), Royal Manchester Children’s Hospital Manchester, United Kingdom; Manchester Royal Infirmary (A.I.-A.), Manchester, UK; Cardiovascular Research Group (A.H.), Department of Medicine, Manchester Royal Infirmary, Manchester, UK; Biostatistics Group (S.A.R.), School of Epidemiology and Health Sciences, Manchester University, Manchester, UK.

Correspondence to Maurice Super, MD FRCP, FRCPCH, Consultant Paediatric Geneticist, Department of Clinical Genetics, Royal Manchester Children’s Hospital, Manchester, M27 4HA United Kingdom. E-mail maurice.super{at}man.ac.uk

Individuals homozygous for the autosomal recessive disorder CF are known to have low blood pressure, thought to be caused by greatly increased sweat salt loss. We examined whether carriers of the CF gene also have low blood pressure. Our pilot studies had suggested an effect limited to females, leading to 2 further studies in white females. In the first, blood pressure was measured in 232 known CF mutation carriers and compared with 246 mutation-negative control subjects. The carriers showed a significantly lower rate of increase in systolic blood pressure with age than the controls, especially after age 50 (3.5% per decade compared with 5.4% per decade, P=0.010). In a small substudy, sweat sodium and chloride levels were highest in those CF carriers with the lowest blood pressures. In the second study, CF carrier status was investigated in 563 normotensive females and in 607 women with essential hypertension diagnosed to test whether a lower incidence of carriers in the hypertensives suggested a protective effect. Twenty-five of the normotensives (4.4%) were carriers compared with 21 (3.5%) of the hypertensive group (P=0.45). Older CF carrier females had lower systolic and diastolic pressures than matched control subjects, with a tendency for blood pressure to increase less with age. This could result in significant reduction in stroke and heart disease. The effect on blood pressure is insufficient to prevent hypertension, though it remains conceivable that the severity might be ameliorated in carriers.

Key Words: blood pressure • women • DNA • mutation